SCHEMBL19345940

SCHEMBL19345940

NC(=O)NSc1ccc(N)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.42
TSHR P16473 2/20 0.42
MAPK1 P28482 1/20 0.42
MAPT P10636 6/20 0.40
RAB9A P51151 2/20 0.40
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
TDP1 Q9NUW8 4/20 0.36
LMNA P02545 2/20 0.36
POLB P06746 2/20 0.36
PKM P14618 1/20 0.36
APEX1 P27695 1/20 0.36
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 3/20 0.35
PARP10 Q53GL7 1/20 0.35
CYP2C9 P11712 1/20 0.35
HPGD P15428 1/20 0.35
CYP2C19 P33261 1/20 0.35
TXNRD1 Q16881 1/20 0.34
TXNRD3 Q86VQ6 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL158241 0.80 SIRT1 (0.42) CYP3A4TSHRMAPTRAB9AMEN1
SCHEMBL4558245 0.78 NPC1 (0.41) TSHRMAPTRAB9ALMNAKDM4E
SCHEMBL24325340 0.76 ALDH1A1 (0.54) MAPK1MAPTRAB9AMEN1KMT2A
SCHEMBL6465460 0.75 TSHR (0.52) TSHRMAPK1MAPTMEN1KMT2A
SCHEMBL14268630 0.75 KMT2A (0.50) CYP3A4MAPK1MAPTRAB9AMEN1
SCHEMBL28646192 0.75 NNMT (0.47) ALDH1A1KDM4ESMN1; SMN2HSD17B10GAA
SCHEMBL6562201 0.72 EPHX1 (0.51) MAPTRAB9AMEN1KMT2ALMNA
SCHEMBL6034931 0.72 MTNR1A (0.42) CYP3A4MAPTRAB9ALMNAALDH1A1
SCHEMBL23181647 0.71 CYP3A4 (0.55) CYP3A4TSHRMAPK1MAPTRAB9A
SCHEMBL23732780 0.69 HDAC2 (0.51) MAPTRAB9AMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017156181-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-09-14 WO disclosed
CN-101466692-A Thiazol-guanidine derivatives useful as a (beta) - related pathologies ASTRAZENECA AB (SE) 2009-06-24 CN disclosed